This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program.
Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% Continue to STAT+ to read the full story…
The federal government will not modify regulations that dictate how hospitals publish their prices for consumers, ignoring pleas from patient advocates who have said hospitals still are not fully complying with the 3-year-old law. The Biden administration on Wednesday proposed an annual rule that sets payment rates for hospitals.
The California Public Employees’ Retirement System is making a drastic change to one of its major health insurance plans for the state’s employees and retirees: It’s switching health insurance carriers, and forcing its new partners to earn their fees instead of automatically getting them.
But they could severely warp the economics of local markets for patients, employers, and insurers — and Lina Khan’s Federal Trade Commission is eager to make Big Physician a lot smaller. Read the rest…
A new report explains the flow of dollars through the pharmaceutical supply chain for commercially insured patients taking retail medicines and details how transactions between stakeholders affect patient costs at the pharmacy counter.
The earliest a generic version may be available is 2025, but that’s not guaranteed. Is Incruse Ellipta covered by insurance? Some health insurance plans or Medicare drug plans cover Incruse Ellipta, but coverage varies by plan. Insurance plans tend to put Incruse Ellipta in their top drug tiers, so copay costs may be high.
WASHINGTON (AP) — President Biden on Friday rolled out a new set of initiatives to reduce health care costs: a crackdown on scam insurance plans, new guidance to prevent surprise medical bills and an effort to reduce medical debt tied to credit cards. Read the rest…
What to make of the 2025 Medicare enrollment season In four weeks, Medicare beneficiaries will be able to sign up for 2025 coverage. CVS Health and Humana have been the most vocal major insurers about scaling back their Medicare Advantage plan offerings to improve profits.
Without insurance, Rexulti costs over $1,900 per month. Each insurance plan has a list of covered drugs known as a formulary, with drugs assigned certain levels, called “tiers.” There is such a big variation among the various insurance plans and what they charge,” says Selly Vazquez , an insurance specialist in Brookfield, Connecticut.
Waiting list numbers for routine hospital treatment in the UK, already at around six million people, will rise and are unlikely to start falling for at least two years, according to Health Secretary Sajid Javid. Today we published our plan to tackle the Covid Backlog: deliver 9 million more tests, checks & procedures by 2025.
Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. Let’s explore how this technology impacts insurance companies, healthcare providers (HCPs), pharma content , and pharmaceutical brands. HCPs The pandemic exposed many flaws in healthcare.
This trend is likely to continue with specialty medications expected to account for 65 percent of drug spending by 2025. Establishing entity-owned specialty pharmacies is an effective way for hospitals and health systems to improve access to specialty medications, gain control over the distribution process, and cut overall costs.
This new study reinforced the validity of this association in a sample of commercial insurance and Medicare beneficiaries with diabetes. Persistent individuals were also associated with fewer emergency department visits and hospital readmissions, and the association further extended to lower diabetes-related medical costs.
There are also a number of proposed specific prohibited uses of the data, including advertising or marketing towards health professionals, or use of the data for the purpose of tailoring insurance premiums. When will it come into force?
By 2025, people on Medicare who take expensive medications will feel significant financial relief : They will not have to pay more than $2,000 in a year for all of their drugs.
With reduced EF, empagliflozin was associated with a reduced risk of cardiovascular death and reduced risk of hospitalization for CHF when compared with placebo. A one-month supply of Jardiance can cost over $800 without insurance , but some insurance plans and most Medicare and Medicaid plans cover it.
February 2024 saw UHGs Change Healthcare crippled by a ransomware attackan attack so severe that hospitals shut down operations, surgeries were delayed, and patients were left in limbo. And those numbers dont even touch private plans, where insurers are notorious for keeping denial data hidden. This isnt just an IT problem.
WASHINGTON — President Biden on Monday unveiled his requests for the 2025 budget, potentially his last chance to cement a legacy on drug costs, cancer research, and broad health care coverage. The president’s $130.7 billion proposal is a dip from the $144.3 Continue to STAT+ to read the full story…
As of January 2025, only the Prasco version of dapagliflozin is available in pharmacies. Without insurance, a one-month supply of 10 mg brand-name Farxiga costs about $812. years longer without experiencing serious heart-related events (such as hospitalization , death, or worsening of their condition).
Taking stock of the 2025 MA proposals If there’s one thing to take away from CMS’ newest proposals for Medicare Advantage plans, it’s that the Biden administration didn’t really want to rock the boat in an election year. You’re reading the web version of Health Care Inc.,
We aim to give pharmacists the tools they need to contribute meaningfully to cancer care, says Professor Meier, and this structured approach underscores the specialisms role within the broader hospital pharmacy framework, as well as its pivotal contribution to multidisciplinary cancer care teams.
Because Stelara is expensive without insurance, averaging $37,052 per syringe, you may want to know if there is a generic available that can help save money. There have been several biosimilars approved, including Wezlana , Selarsdi, and Pyzchiva, but they are not expected to be available until early 2025. What is a biosimilar?
The COVID-19 pandemic underscores the importance of DHTs through the increased reliance on telemedicine services and remote patient monitoring programs to ensure patient safety and triage scarce hospital resources. Global Strategy on Digital Health 2020-2025.” Calculates insulin dose based on a proprietary algorithm that incorporates.
For adults with chronic kidney disease (CKD), it’s approved to reduce the risk of kidney disease progression, hospitalization for heart failure, and death due to cardiovascular disease. For adults with Type 2 diabetes and heart disease or risk factors for heart disease, it’s approved to reduce the risk of hospital visits.
Fortunately, most Medicare and commercial insurance plans cover Jardiance. Original Medicare Parts A and B provide health insurance for inpatient and outpatient health services respectively, among other services. With Medicare coverage, the average patient can expect to pay up to $20 monthly for Jardiance.
As an immunosuppressive medicine, Stelara affects the immune system, which increases the risk of infections, including serious infections that require hospitalization. You may want to have a family member, caregiver, or friend drive you to and from your appointment in case you experience dizziness or other side effects.
We recently engaged with a number of our investment banking clients to discuss their M&A outlook 2025. The M&A outlook 2025 for AI-powered firms thus appears promising. Reduced government funding for public healthcare programs may increase financial pressure on hospitals and insurers, creating consolidation opportunities.
On International Womens Day (8 March 2025), senior reporter Joanna Robertson spoke to Lourette Philips, president of the National Association of Women Pharmacists (NAWP), at the networks 120-year celebration in Birmingham, discussing its history, progress and the future of women in pharmacy. I’ve been with the PDA since I qualified.
The American Hospital Association has warned that increased costs and delays in sourcing critical drugs could lead to shortages of essential medicines, including antibiotics, oncology treatments, and cardiovascular drugs. However, in the long term, increased costs could be passed on to healthcare systems, insurers, and ultimately, patients.
Enhanced tax credits that help millions of middle-income Americans afford health plans on the ACA’s individual marketplaces, signed into law by President Biden, expire at the end of 2025.
WASHINGTON — Health care did not play a big role in the election that’s sending President Trump back to the White House and giving Republicans control of Congress. That doesn’t mean Congress will avoid the topic next year.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content